[Infliximab and amyloidosis secondary to inflammatory bowel diseases].
Callejas Rubio
José Luis
JL
Ortego Centeno
Norberto
N
Cárdeña Pérez
Carlos
C
Navas-Parejo
Antonio
A
D000328:Adult; D000686:Amyloidosis / Q000188:drug therapy* / Q000209:etiology*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D007674:Kidney Diseases / Q000188:drug therapy / Q000209:etiology; D014409:Tumor Necrosis Factor-alpha
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab